Sumitomo Mitsui DS Asset Management Company Ltd Purchases 497 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 3.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,491 shares of the company’s stock after purchasing an additional 497 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Henry Schein were worth $934,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in HSIC. Cromwell Holdings LLC grew its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the last quarter. Versant Capital Management Inc boosted its position in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares during the period. City State Bank acquired a new stake in shares of Henry Schein in the fourth quarter worth $55,000. Farther Finance Advisors LLC increased its position in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the period. Finally, Mather Group LLC. raised its stake in Henry Schein by 43.7% during the 4th quarter. Mather Group LLC. now owns 1,503 shares of the company’s stock valued at $104,000 after purchasing an additional 457 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Down 1.8 %

Shares of NASDAQ:HSIC opened at $77.48 on Wednesday. The company’s fifty day moving average is $73.80 and its 200-day moving average is $71.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a market capitalization of $9.66 billion, a PE ratio of 31.88, a P/E/G ratio of 2.21 and a beta of 0.91.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on HSIC shares. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research upped their price target on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Seven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $80.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.